Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Observational, Non-interventional Registry Designed to Collect Clinical Data in Chinese Patients Who Have Received CUBICIN® Treatment Under Condition of Actual Usage in Clinical Practice

NCT01212601 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01212601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01212601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Observational, Non-interventional Registry Designed to Collect Clinical Data in Chinese Patients Who Have Received CUBICIN® Treatment Under Condition of Actual Usage in Clinical Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2012
Enrollment
203 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

s. aureus bloodstream infection